retatrutide triple agonist glp-1 gip glucagon receptors Demonstrated metabolic effects of GIP, and GCG agonism as mono, Calling retatrutide a “GLP-3” is
Description
doi: 10.3390/nu11010053, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 8
This approach isn't suitable for everyone, particularly those with diabetes on insulin or sulfonylureas, pregnant or breastfeeding women, people with a history of eating disorders, those with kidney disease, or frail individuals
Cureus 15, e39011
Maximus Tribe is one of many telehealth programs in the GLP-1 / weight management space
That said, the effect size of this circadian alignment is likely small compared to the overall impact of the drug itself
